The COL2A1 gene homepage

General information
Gene symbol COL2A1
Gene name collagen, type II, alpha 1
Chromosome 12
Chromosomal band q12-q13.2
Imprinted Unknown
Genomic reference NG_008072.1
Transcript reference NM_001844.4
Exon/intron information NM_001844.4 exon/intron table
Associated with diseases ACG, ACG2, ANFH1, EDMMD, ID, Kniest, LCPD, OSCDP, OSMEDB, PLSDT, SED, SEDC, SEDN, SEDSTN, SEDT, SEMDSTWK, SPDA, STL1, dysplasia, Czech, dysspondylo-enchondromatose, Stickler sydrome, type I, nonsyndromic ocular, vitreoretinopathy, with phalangeal epiphyseal dysplasia
Citation reference(s) -
Refseq URL Genomic reference sequence
Curators (2) Mouna Barat-Houari and Isabelle Touitou
Total number of public variants reported 1347
Unique public DNA variants reported 770
Individuals with public variants 2195
Hidden variants 19
Download all this gene's data Download all data
Notes Establishment of this gene variant database (LSDB) was supported by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement No 200754 - the GEN2PHEN project.
Date created April 29, 2010
Date last updated November 27, 2023
Version COL2A1:231127

Graphical displays and utilities
Graphs Graphs displaying summary information of all variants in the database »
Reading frame checker The Reading-frame checker generates a prediction of the effect of whole-exon changes. Active for: NM_001844.4.
UCSC Genome Browser Show variants in the UCSC Genome Browser (full view, compact view)
Ensembl Genome Browser Show variants in the Ensembl Genome Browser (full view, compact view)
NCBI Sequence Viewer Show distribution histogram of variants in the NCBI Sequence Viewer

Links to other resources
HGNC 2200
Entrez Gene 1280
PubMed articles COL2A1
OMIM - Gene 120140
OMIM - Diseases ACG2 (achondrogenesis, type II (hypochondrogenesis, ACG-2))
ANFH1 (necrosis, avascular, femoral head (ANFH))
EDMMD (dysplasia, epiphyseal, multiple, with myopia and deafness (EDMMD))
Kniest (dysplasia, Kniest)
LCPD (Legg-Calve-Perthes disease (LCPD))
OSCDP (osteoarthritis, with mild chondrodysplasia (OSCDP))
OSMEDB (Otospondylomegaepiphyseal dysplasia, autosomal recessive)
PLSDT (dysplasia, skeletal, platyspondylic, Torrance type (PLSDT))
SED (dysplasia, spondyloperipheral (SED))
SEDC (dysplasia, spondyloepiphyseal, congenita (SEDC))
SEDSTN (Spondyloepiphyseal dysplasia, Stanescu type)
SEMDSTWK (dysplasia, spondyloepimetaphyseal, Strudwick type (SEMDSTWK))
STL1 (Stickler syndrome, type I (STL-1))
dysplasia, Czech
Stickler sydrome, type I, nonsyndromic ocular
GeneCards COL2A1
Orphanet COL2A1

Active transcripts




NCBI ID     

NCBI Protein ID     

00005457 12 transcript variant 1 NM_001844.4 NP_001835.3 1347

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective submitter(s) and curator(s) of the individual records. Individual data entries may indicate which data license applies to that specific record. When no license is listed, no permissions are granted. Any unauthorized use, copying, storage, or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2010-2023. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising from any inaccuracies or omissions. Individuals, organizations, and companies that use this database do so on the understanding that no liability whatsoever, either direct or indirect, shall rest upon the data submitter(s), curator(s), or any of their employees or agents for the effects of any product, process, or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.